Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England : Results of a Modified Prescription-Event Monitoring Study.
Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Vitamin D and multiple sclerosis.
Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Exosomes in neurologic and psychiatric disorders.
Association of Postoperative Outcomes with Preoperative MRI for Patients with Concurrent Multiple Sclerosis and Cervical Stenosis.
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Multiple sclerosis in Sistan and Baloochestan, South East Iran.
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
What is new in MS spasticity research? Poster session highlights.
Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis.
Environmental factors in multiple sclerosis.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord.]
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
A Qualitative Study Exploring the Usability of Nintendo Wii Fit among Persons with Multiple Sclerosis.
Teriflunomide for the treatment of multiple sclerosis.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »